Ken Suzawa Selected Research

Ken Suzawa Research Topics

Disease

30	Neoplasms (Cancer) 05/2024 - 03/2014
22	Lung Neoplasms (Lung Cancer) 04/2024 - 03/2015
18	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2024 - 01/2014
7	Neoplasm Metastasis (Metastasis) 02/2024 - 01/2018
4	Sarcoma (Soft Tissue Sarcoma) 12/2023 - 01/2021
4	Breast Neoplasms (Breast Cancer) 11/2021 - 01/2017
3	Bronchiolitis Obliterans Syndrome 11/2023 - 02/2022
2	Radiation Pneumonitis 03/2024 - 08/2020
2	Adenocarcinoma of Lung 02/2024 - 01/2020
2	Primary Graft Dysfunction 02/2024 - 10/2018
2	Lymphatic Metastasis 10/2023 - 01/2022
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 04/2023 - 01/2021
2	Ischemia 11/2022 - 10/2021
2	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2022 - 01/2021
2	Lung Injury 10/2021 - 01/2021
1	Critical Illness (Critically Ill) 05/2024
1	Postoperative Hemorrhage 04/2024
1	Acute Lung Injury 02/2024
1	Sepsis (Septicemia) 02/2024
1	Carcinoma (Carcinomatosis) 01/2024
1	Leiomyosarcoma 12/2023
1	Adenocarcinoma 10/2023
1	Hemorrhage 01/2023
1	Melanoma (Melanoma, Malignant) 09/2022
1	Reperfusion Injury 10/2021
1	Castleman Disease (Castleman's Disease) 09/2021
1	Fistula 02/2021
1	Fibrosis (Cirrhosis) 01/2021
1	Idiopathic Pulmonary Fibrosis 01/2021
1	Inflammation (Inflammations) 01/2021
1	Persistent Infection 01/2021
1	Pulmonary Aspergillosis 08/2020

Drug/Important Bio-Agent (IBA)

15	Tyrosine Kinase InhibitorsIBA 02/2024 - 03/2015
6	ErbB Receptors (EGF Receptor)IBA 02/2024 - 03/2015
5	Proteins (Proteins, Gene)FDA Link 09/2022 - 12/2016
5	human ERBB2 proteinIBA 11/2021 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 05/2024 - 10/2018
4	AfatinibIBA 05/2018 - 10/2015
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2017
2	CatecholaminesIBA 04/2024 - 03/2014
2	histidine-rich proteinsIBA 02/2024 - 09/2022
2	PeriostinIBA 12/2023 - 12/2023
2	MicroRNAs (MicroRNA)IBA 04/2023 - 01/2017
2	Trastuzumab (Herceptin)FDA Link 11/2021 - 01/2017
2	Monoclonal AntibodiesIBA 10/2021 - 09/2021
2	Carrier Proteins (Binding Protein)IBA 10/2021 - 12/2016
2	Phosphotransferases (Kinase)IBA 12/2020 - 01/2018
2	neratinibIBA 03/2020 - 03/2019
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018 - 12/2016
1	Indicators and Reagents (Reagents)IBA 05/2024
1	Epinephrine (Adrenaline)FDA LinkGeneric 04/2024
1	Adrenergic Agents (Adrenergic Drugs)IBA 04/2024
1	EnzymesIBA 04/2024
1	Glycoproteins (Glycoprotein)IBA 02/2024
1	Plasminogen Activator Inhibitor 1IBA 01/2024
1	CrizotinibIBA 01/2024
1	RNA (Ribonucleic Acid)IBA 12/2023
1	AntibodiesIBA 12/2023
1	tranilastIBA 10/2022
1	osimertinibIBA 10/2022
1	AZD 6244IBA 10/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2022
1	Chemotactic FactorsIBA 09/2022
1	Blood Proteins (Serum Proteins)IBA 09/2022
1	Keratin-19 (Keratin 19)IBA 01/2022
1	Nucleic AcidsIBA 01/2022
1	Ado-Trastuzumab EmtansineIBA 11/2021
1	ChromatinIBA 10/2021
1	HMGB1 Protein (HMG1)IBA 10/2021
1	HMGB ProteinsIBA 10/2021
1	salicylhydroxamic acid (SHAM)IBA 10/2021
1	Mitogen-Activated Protein KinasesIBA 10/2021
1	ChemokinesIBA 10/2021
1	CytokinesIBA 10/2021
1	Interleukin-6 (Interleukin 6)IBA 09/2021
1	EnbucrilateIBA 02/2021
1	EquolIBA 01/2021
1	Tamoxifen FDA LinkGeneric 01/2021
1	indium-bleomycinIBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	Dihydrotachysterol (AT 10)IBA 01/2021
1	IsoflavonesIBA 01/2021
1	Hormones (Hormone)IBA 01/2021
1	cabozantinibIBA 12/2020
1	agerafenibIBA 12/2020
1	LY3009120IBA 05/2020
1	Dasatinib (BMS 354825)FDA Link 03/2020

Therapy/Procedure

16	Therapeutics 02/2024 - 01/2016
9	Lung Transplantation 05/2024 - 10/2018
7	Chemoradiotherapy 03/2024 - 04/2015
4	Adjuvant Chemotherapy 03/2024 - 08/2020
4	Metastasectomy 12/2023 - 01/2021
3	Operative Time 04/2024 - 01/2023
2	Molecular Targeted Therapy 10/2022 - 03/2020
1	Drug Therapy (Chemotherapy) 10/2023
1	Thoracotomy 10/2023
1	Mechanical Ventilators (Ventilator) 11/2022
1	Thymectomy 07/2022
1	Intravenous Administration 10/2021
1	Pneumonectomy (Lung Volume Reduction) 02/2021